Atrial fibrillation is associated with increased risks of death, cardiovascular disease, and renal disease, highlighting the need for comprehensive management beyond stroke prevention.
Supports holistic AF management beyond stroke prevention; reinforces multisystem risk associations across extensive meta-analytic data.
Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Odutayo et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: